BRIEF published on 08/25/2026 at 19:35, 10 days 22 hours ago New CEO Appointed at KD Pharma Group Pharmaceutical Industry Leadership Change KD Pharma Group Omega-3 Lipids Manja Boerman
BRIEF published on 08/25/2026 at 19:35, 10 days 22 hours ago Nomination d'un nouveau PDG chez KD Pharma Group Changement De Leadership Industrie Pharmaceutique Groupe KD Pharma Manja Boerman Lipides Oméga-3
PRESS RELEASE published on 08/25/2026 at 19:30, 10 days 22 hours ago Change in the Management Board O3 Holding GmbH announces the appointment of Manja Boerman as Chief Executive Officer of KD Pharma Group, bringing extensive industry expertise in pharmaceutical, biotechnology, and life sciences Pharmaceutical Industry Chief Executive Officer O3 Holding GmbH KD Pharma Group Manja Boerman
BRIEF published on 08/21/2026 at 15:20, 15 days 2 hours ago O3 Holding GmbH Releases Q2 2026 Interim Report Bond Issue O3 Holding GmbH KD Pharma Group Q2 2026 Report Pharmaceutical Lipids
BRIEF published on 08/21/2026 at 15:20, 15 days 2 hours ago O3 Holding GmbH publie son rapport intermédiaire du deuxième trimestre 2026 Emission D'obligations O3 Holding GmbH Groupe KD Pharma Rapport Du Deuxième Trimestre 2026 Lipides Pharmaceutiques
PRESS RELEASE published on 08/21/2026 at 15:15, 15 days 2 hours ago O3 Holding GmbH - Publication Q2 2026 Interim Report O3 Holding GmbH, the parent company of KD Pharma Group, releases Q2 2026 Interim Report in compliance with bond terms, available on their website Pharmaceutical O3 Holding GmbH KD Pharma Group Q2 2026 Interim Report Nutritional Lipids
BRIEF published on 05/29/2026 at 18:05, 3 months 6 days ago O3 Holding GmbH Releases Q1 2026 Interim Report Financial Disclosure Bond Issue O3 Holding GmbH KD Pharma Group Q1 2026 Report
BRIEF published on 05/29/2026 at 18:05, 3 months 6 days ago O3 Holding GmbH publie son rapport intermédiaire du premier trimestre 2026 Déclaration Financière Emission D'obligations O3 Holding GmbH Groupe KD Pharma Rapport Du Premier Trimestre 2026
PRESS RELEASE published on 05/29/2026 at 18:00, 3 months 6 days ago O3 Holding GmbH - Publication Q1 2026 Interim Report O3 Holding GmbH announces the publication of its Q1 2026 Interim Report for its FRN Senior Secured EUR 180,000,000 bond issue. Contact investor.relations@kdpharma.com for more info CDMO Interim Report Q1 2026 O3 Holding GmbH KD Pharma Group
BRIEF published on 03/02/2026 at 11:40, 6 months 3 days ago O3 Holding GmbH Releases Q4 2025 Interim Report Financial Results Bond Issue O3 Holding GmbH KD Pharma Group Q4 2025 Interim Report
Published on 09/05/2026 at 04:05, 13 hours 39 minutes ago Pelican AI Corp. Announces Proposed Share Issuances and Litigation Update
Published on 09/04/2026 at 23:30, 18 hours 14 minutes ago FutureGen Industries Announces Shares for Debt Settlement
Published on 09/04/2026 at 23:00, 18 hours 44 minutes ago Golden Minerals Announces Management Change and Argentine Project Update
Published on 09/04/2026 at 22:30, 19 hours 14 minutes ago Panther Minerals Closes Brokered Private Placement of $3,000,000
Published on 09/04/2026 at 14:30, 1 day 3 hours ago Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF)
Published on 09/05/2026 at 14:00, 3 hours 44 minutes ago Global investment boom could create USD 200 billion commercial insurance opportunity amid rising accumulation risks, finds Swiss Re Institute
Published on 09/05/2026 at 09:05, 8 hours 38 minutes ago CHiQ Wins AI Home Ecosystem Brand Award, Exploring New Smart Living Experiences Through AI Innovation
Published on 09/04/2026 at 22:10, 19 hours 33 minutes ago Quantinuum to Participate in the Bernstein 23rd Annual Pan-European Strategic Decisions Conference
Published on 09/04/2026 at 19:20, 22 hours 23 minutes ago Dahua Technology Showcases Integrated Smart Living and Innovations at IFA Berlin 2026
Published on 09/04/2026 at 19:00, 22 hours 44 minutes ago INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL
Published on 09/04/2026 at 18:57, 22 hours 47 minutes ago Disclosure of transactions in own shares from September 1 to September 4, 2026
Published on 09/04/2026 at 18:57, 22 hours 47 minutes ago Déclaration hebdomadaire d'opérations effectuées du 1er au 4 septembre 2026
Published on 09/04/2026 at 18:15, 23 hours 29 minutes ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 09/04/2026 at 18:15, 23 hours 29 minutes ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 09/04/2026 at 18:15, 23 hours 29 minutes ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES AOÛT 2026
